Flash | 20 Aug 2026 10:50:56 ET │ 16 pages China Healthcare Services mRNA Cancer Vaccines: Assessing Read-through for Chinese Healthcare companies after Moderna's Phase III Success CITI'S TAKE Moderna's Phase III success provides important proof of concept that mRNA vaccination can generate clinically meaningful outcomes in oncology, but there are still multiple challenges remaining to be addressed before its broader use in cancer treatment in our view, e.g. clinical efficacy validation in indications beyon ...